Summary
Fractionation of immune complexes (IC) from rheumatoid synovial fluid revealed the presence of three different fractions of IC. The largest molecular weight form, fraction I (above 1000 Kdaltons) was predominately composed of IgG and IgM and contained both IgM-RF and IgG-RF. The other IC, fraction II (480 Kdaltons) and fraction III (330 Kdaltons), contained predominately IgG with some IgA and only significant amounts of IgG-RF. All three fractions of IC can bind Clq and stimulate human monocyte prostaglandin E (PGE) production. Fraction I IC bound Clq most readily while fraction III IC were the most effective stimulators of monocyte PGE production. IC stimulation of monocyte PGE production was inhibited by staphylococcus protein A suggesting mediation via activation of Fc receptors. It remains to be determined whether this IC reactivity has any pathologic significance.
Similar content being viewed by others
References
Franklin EC, Holman HR, Muller-Eberhard HJ, Kunkel HG (1957) An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis. J Exp Med 105:425–438
Kunkel HG, Muller-Eberhard HJ, Fudenberg HH, Tomasi TB (1961) Gammaglobulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest 40:117–129
Hannestad K (1967) Presence of aggregated γ-G-globulin in certain rheumatoid synovial fluids. Clin Exp Immunol 2:511–515
Winchester RJ, Angello V, Kunkel HG (1970) Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels. Clin Exp Immunol 6:689–706
Winchester RA (1975) Characterization of IgG complexes in patients with rheumatoid arthritis. Ann NY Acad Sci 256:73–81
Fish AJ, Micheal AF, Gewurz H, Good RA (1966) Immunopathologic changes in rheumatoid arthritis synovium. Arthritis Rheum 9:267–273
Rodman WS, Williams RC, Bilka PJ, Muller-Eberhard HJ (1967) Immunofluorescent localization of the third and the fourth component of complement in synovial tissue from patients with rheumatoid arthritis. J Lab Clin Med 69:141–149
Cooke TD, Hurd ER, Jasin HE, Bienenstock J, Ziff M (1975) Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum 18:541–545
Kinsella TD, Baum J, Ziff M (1970) Studies of isolated synovial lining cells of rheumatoid and nonrheumatoid synovial membranes. Arthritis Rheum 13:734–738
Britton MC, Schur PH (1971) The complement system in rheumatoid synovitis. II. Intracytoplasmic inclusions of immunoglobulins and complement. Arthritis Rheum 14:87–92
Pekin TJ, Zvaifler NJ (1964) Hemolytic complement in synovial fluid. J Clin Invest 43:1372–1381
Munthe E, Natvig JB (1972) Complement-fixing intracellular complexes of IgG rheumatoid factor in rheumatoid plasma cells. Scand J Immunol 1:217–229
Brown PB, Nardella FA, Mannik M (1982) Human complement activation by self-associated IgG rheumatoid factors. Arthritis Rheum 25:1101–1107
Ruddy S, Austen KF (1970) The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids. Arthritis Rheum 13:713–723
Nardella FA, Dayer JM, Roelke M, Krane SM, Mannik M (1983) Self-associating IgG rheumatoid factors stimulate monocytes to release prostaglandins and mononuclear cell factor that stimulates collagenase and prostaglandin production by synovial cells. Rheumatol Int 3:183–186
Male D, Roitt IM (1979) Analysis of the components of immune complexes. Mol Immunol 16:197–203
Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:235–254
Robson RM, Goll DE, Temple MJ (1968) Determination of proteins in “Tris” buffer by the Biuret reaction. Anal Biochem 24:339–346
Singer JM, Plotz CM (1956) The latex fixation test one application to the serologic diagnosis of rheumatoid arthritis. Am J Med 12:888–892
Engvall E (1980) Enzyme immuno-assay, ELISA and EMIT. Methods Enzymol 70:419–439
Johnson RB Jr, Libby R (1980) Separation of IgM essentially free of IgG from serum for use in systems requiring assay of IgM-type antibodies without interference from rheumatoid factor. J Clin Microbiol 12:451–454
Gutierrez-Cernosak RM, Morril LM, Levine L (1972) Prostaglandin F2 levels in peripheral sera of man. Prostaglandins 1:71
Pohl DA, Tsaic C, Roodman ST (1981) Detection of immune complexes using a solid-phase Clq polystyrene ball assay. J Immunol Methods 40:313–330
Valone FH, Austen F, Goetzl EJ (1979) Identification of platelet activating activity in rheumatoid synovial fluid as an intermediate molecular weight complex of IgG. J Immunol 122:703–709
Pope RM, Teller DC, Mannik M (1975) Intermediate complexes formed by self-association of IgG-rheumatoid factors. Ann NY Acad Sci 256:82–87
Pope RM, McDuffy D (1979) IgG rheumatoid factor relationship to seropositive rheumatoid arthritis and absence in seronegative disorders. Arthritis Rheum 22:988–998
Highton J, Panay GS, Shepherd P, Faith A, Griffin J, Gibson T (1981) Fall in immune complex levels during gold treatment of rheumatoid arthritis. Ann Rheum Dis 40:575–579
Reynolds WJ, Yoon SJ, Newkiak M, Klein MH (1984) IgA-related disorders in rheumatoid arthritis. Arthritis Rheum 17:S-66 (abstr)
Male D, Roitt IM, Hay FC (1980) Analysis of immune-complexes in synovial effusions with rheumatoid arthritis. Clin Exp Immunol 39:297–306
Rovzer CA, Scott WA, Kempe J, Cohn ZA (1980) Prostaglandin synthesis by macrophages requires a specific receptor — ligand interaction. Proc Natl Acad Sci USA 77:4279–4282
Goodwin JS, Bankhurst AD, Messner RP (1974) Suppression of human T-cell mitogenesis by prostaglandin. J Exp Med 146:1719–1723
Cameron DJ, Rittenberg M, Majeski JM (1984) Ability of cancer patients macrophage to kill autologous tumor cells. Effect of prostaglandin inhibitors on cytoxicity. Cancer 3:2055–2057
Thompson PA, Jelinek DF, Lipsky PE (1984) Regulation of human B cell proliferation by prostaglandin E2. J Immunol 133:2446–2453
Boraschi D, Censini S, Tagliabue A (1984) Interferon — reduces macrophage — suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin-1 production. J Immunol 133:764–769
Bona IL, Parnham MJ, VanVliet L (1978) Combination of theophylline and prostaglandin E1 as inhibitors of the adjuvant-induced arthritis syndrome of rats. Ann Rheum Dis 37:212–217
Binderup L (1983) Lymphocyte-macrophage co-operation during induction of T suppressor cell activity in rats with adjuvant arthritis. Ann Rheum Dis 42:687–692
Panayi GS, Conigall V, Youlten LIF (1981) Immunoregulation in the rheumatoid diseases. Scand J Rheumatol [Suppl] 38:9–21
Hasler F, Bluestein HG, Zvaifler NJ, Epstein LB (1983) Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E. J Immunol 131:768–772
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mochan, E., Passon, T.J. Properties and reactivity of immune complexes in rheumatoid synovial fluid. Rheumatol Int 6, 103–109 (1986). https://doi.org/10.1007/BF00270345
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00270345